Acumen Pharmaceuticals CEO Daniel O'Connell's 2021 pay jumps 340% to $1.5M
Acumen Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 27, 2022
Acumen Pharmaceuticals reported fiscal year 2021 executive compensation information on April 27, 2022.
In 2021, three executives at Acumen Pharmaceuticals received on average a compensation package of $965K, a 236% increase compared to previous year.
Average pay of disclosed executives at Acumen Pharmaceuticals
Daniel O'Connell, Chief Executive Officer, received $1.5M in total, which increased by 340% compared to 2020. 46% of O'Connell's compensation, or $676K, was in option awards. O'Connell also received $275K in non-equity incentive plan, $525K in salary, as well as $1.6K in other compensation.
Matthew Zuga, Chief Financial Officer, received a compensation package of $779K. 41% of the compensation package, or $315K, was in salary.
Eric Siemers, Chief Medical Officer, earned $638K in 2021, a 168% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2022.